Plk1 regulates mitotic Aurora A function through βTrCP-dependent degradation of hBora

por Chan, Eunice H. Y., Santamaria, Anna, Silljé, Herman H. W., Nigg, Erich A.
Publicado 2008

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

por Suthahar, Navin, Meijers, Wouter C., Silljé, Herman H.W., de Boer, Rudolf A.
Publicado 2017

Regulation of the (pro)renin–renin receptor in cardiac remodelling

por Mahmud, Hasan, Silljé, Herman H W, Cannon, Megan V, Gilst, Wiek H, Boer, Rudolf A
Publicado 2012

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?

por Piek, Arnold, Suthahar, Navin, Voors, Adriaan A., de Boer, Rudolf A., Silljé, Herman H.W.
Publicado 2020

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

por Yurista, Salva R., Silljé, Herman H. W., Rienstra, Michiel, de Boer, Rudolf A., Westenbrink, B. Daan
Publicado 2020

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

por Stege, Nienke M., de Boer, Rudolf A., van den Berg, Maarten P., Silljé, Herman H. W.
Publicado 2021

Human TPX2 is required for targeting Aurora-A kinase to the spindle

por Kufer, Thomas A., Silljé, Herman H.W., Körner, Roman, Gruss, Oliver J., Meraldi, Patrick, Nigg, Erich A.
Publicado 2002

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population

por Piek, Arnold, Smit, Leonie, Suthahar, Navin, Bakker, Stephan J. L., de Boer, Rudolf A., Silljé, Herman H. W.
Publicado 2021

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

por Suthahar, Navin, Meijers, Wouter C., Silljé, Herman H.W., Ho, Jennifer E., Liu, Fu-Tong, de Boer, Rudolf A.
Publicado 2018

The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro

por Lu, Bo, Mahmud, Hasan, Maass, Alexander H., Yu, Bo, van Gilst, Wiek H., de Boer, Rudolf A., Silljé, Herman H. W.
Publicado 2010

AKIP1, a Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt Pathway

por Yu, Hongjuan, Tigchelaar, Wardit, Lu, Bo, van Gilst, Wiek H., de Boer, Rudolf A., Westenbrink, B. Daan, Silljé, Herman H. W.
Publicado 2013

Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling

por Piek, Arnold, Koonen, Debby P. Y., Schouten, Elisabeth-Maria, Lindtstedt, Eva L., Michaëlsson, Erik, de Boer, Rudolf A., Silljé, Herman H. W.
Publicado 2019

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

por Yurista, Salva R., Silljé, Herman H. W., Nijholt, Kirsten T., Dokter, Martin M., van Veldhuisen, Dirk J., de Boer, Rudolf A., Westenbrink, B. Daan
Publicado 2020

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin

por Ruifrok, Willem-Peter T., Qian, Cheng, Silljé, Herman H. W., van Goor, Harry, van Veldhuisen, Dirk J., van Gilst, Wiek H., de Boer, Rudolf A.
Publicado 2010

Evaluation of renal cancer progression in a mouse model of heart failure

por Shi, Canxia, Aboumsallem, Joseph Pierre, de Wit, Sanne, Schouten, Elisabeth Maria, Bracun, Valentina, Meijers, Wouter C., Silljé, Herman H.W., de Boer, Rudolf A.
Publicado 2021

Metabolic Remodeling in the Pressure‐Loaded Right Ventricle: Shifts in Glucose and Fatty Acid Metabolism—A Systematic Review and Meta‐Analysis

por Koop, Anne‐Marie C., Bossers, Guido P. L., Ploegstra, Mark‐Jan, Hagdorn, Quint A. J., Berger, Rolf M. F., Silljé, Herman H. W., Bartelds, Beatrijs
Publicado 2019

AKIP1 Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes

por Yu, Hongjuan, Tigchelaar, Wardit, Koonen, Debby P. Y., Patel, Hemal H., de Boer, Rudolf A., van Gilst, Wiek H., Westenbrink, B. Daan, Silljé, Herman H. W.
Publicado 2013

LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

por Cannon, Megan V., Silljé, Herman H. W., Sijbesma, Jürgen W. A., Khan, Mohsin A. F., Steffensen, Knut R., van Gilst, Wiek H., de Boer, Rudolf A.
Publicado 2015

Circulating immune checkpoints predict heart failure outcomes

por Screever, Elles M., Yousif, Laura I.E., Moslehi, Javid J., Salem, Joe‐Elie, Voors, Adriaan A., Silljé, Herman H.W., de Boer, Rudolf A., Meijers, Wouter C.
Publicado 2023

Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production

por Du, Weijie, Piek, Arnold, Schouten, E. Marloes, van de Kolk, Cees W.A., Mueller, Christian, Mebazaa, Alexandre, Voors, Adriaan A., de Boer, Rudolf A., Silljé, Herman H.W.
Publicado 2018